Displaying 106 - 126 of 212 results
Syensqo first quarter 2026 results
Net sales of €1.4 billion, increased 5% sequentially, led by Specialty Polymers and Novecare; Underlying EBITDA of €251 million, increased 6% sequentially, led by Specialty Polymers; Full year 2026 underlying EBITDA outlook unchanged, with capital expenditure lowered by up to €50 million
Syensqo News
Subscribe to receive Syensqo news and press releases in your mailbox
Contact us
Contact our team for any media or public relations questions